Trade PRME anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Prime Medicine, Inc. (PRME) is trading at US$3.63, down 0.38% today as of Aug 28, 11:08 EDT. The company has a market capitalisation of US$614.87M. Over the past 52 weeks, PRME has traded between US$2.67 and US$6.94. On Syfe you can trade PRME with $0 commission and add it to your watchlist.
| Previous close | US$3.64 |
|---|---|
| Market cap | US$614.87M |
| 52-week range | US$2.67 – US$6.94 |
| Volume | 1.83M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Prime Medicine, Inc.
Prime Medicine, Inc. is a biotechnology company, which engages in developing one-time curative genetic therapies. The company was founded by David R. Liu on September 13, 2019 and is headquartered in Cambridge, MA.
Year: 2022
Update: Prime Medicine Receives Favorable Ruling in Beam Therapeutics License Arbitration; Shares Rise
Jul 8, 6:08 PM · MT Newswires
Prime Medicine Receives Favorable Ruling in Beam Therapeutics License Arbitration
Jul 8, 4:02 PM · MT Newswires
--HC Wainwright Upgrades Prime Medicine to Buy From Neutral, $8 Price Target
Jun 29, 11:35 AM · MT Newswires
Prime Medicine Says PM359 Granted US FDA Regenerative Medicine Advanced Therapy Designation
Jun 22, 12:27 PM · MT Newswires
Prime Medicine Names Svetlana Makhni CFO
Apr 16, 1:02 PM · MT Newswires
Prime Medicine, Inc. (PRME) stock is trading at US$3.63, -0.38% from the previous close of US$3.64.
The market cap for Prime Medicine, Inc. (PRME) stock is approximately US$614.87M.
The 52-week high for Prime Medicine, Inc. (PRME) stock is US$6.94.
The 52-week low for Prime Medicine, Inc. (PRME) stock is US$2.67.
Prime Medicine, Inc. (PRME) does not currently pay a dividend.
Stay on top of PRME
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
